. 2003 Winter;5(1):61-3.

Chemoprevention and prostate cancer

Masood A Khan et al. Rev Urol. 2003 Winter.

. 2003 Winter;5(1):61-3.

No abstract available

Similar articles

Current and future status of prostate cancer chemoprevention.
Fujimoto N, Nomura M, Matsumoto T. Fujimoto N, et al. Expert Rev Anticancer Ther. 2006 Jan;6(1):59-71. doi: 10.1586/14737140.6.1.59. Expert Rev Anticancer Ther. 2006. PMID: 16375645 Review.
Prostate cancer chemoprevention agents exhibit selective activity against early stage prostate cancer cells.
Liu YQ, Kyle E, Patel S, Housseau F, Hakim F, Lieberman R, Pins M, Blagosklonny MV, Bergan RC. Liu YQ, et al. Prostate Cancer Prostatic Dis. 2001;4(2):81-91. doi: 10.1038/sj.pcan.4500506. Prostate Cancer Prostatic Dis. 2001. PMID: 12497043
[Chemoprevention of prostate cancer].
Djavan B, Thompson I, Michel MS, Waldert M, Seitz C. Djavan B, et al. Urologe A. 2004 May;43(5):557-61. doi: 10.1007/s00120-004-0537-2. Urologe A. 2004. PMID: 15042290 Review. German.
The cost of prostate cancer chemoprevention: a decision analysis model.
Svatek RS, Lee JJ, Roehrborn CG, Lippman SM, Lotan Y. Svatek RS, et al. Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1485-9. doi: 10.1158/1055-9965.EPI-06-0221. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16896037
Update on prostate cancer chemoprevention.
Lowe JF, Frazee LA. Lowe JF, et al. Pharmacotherapy. 2006 Mar;26(3):353-9. doi: 10.1592/phco.26.3.353. Pharmacotherapy. 2006. PMID: 16503715 Review.

1. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin. 2002;52:23–47. - PubMed
1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin. 1999;49:8–11. - PubMed
1. Kelloff GJ, Higley HR, Brawer MK, et al. Chemoprevention strategies in the prostate: An overview. Rev Urol. 2002;4:69–77. - PMC - PubMed
1. Lieberman R, Bermejo C, Akaza H, et al. Progress in prostate cancer chemoprevention: modulators of promotion and progression. Urology. 2001;58:835–842. - PubMed
1. Heinonen OP, Albanes D, Virlano J, et al. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst. 1998;90:440–446. - PubMed